The influence of the baseline 10-year atherosclerotic cardiovascular disease risk on cardiovascular outcomes with aspirin for primary prevention: a meta-regression analysis

Eur Heart J Qual Care Clin Outcomes. 2020 Apr 1;6(2):175-176. doi: 10.1093/ehjqcco/qcz049.

Authors

Ahmed N Mahmoud¹, Islam Y Elgendy²

Affiliations

¹ Division of Cardiology, University of Washington, Seattle, WA, USA.
² Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, GRB-800, Boston, MA 02114, USA.

PMID: 31553436
DOI: 10.1093/ehjqcco/qcz049

No abstract available

Publication types

Letter
Comment

MeSH terms

Aspirin*
Cardiovascular Diseases*
Humans
Primary Prevention
Randomized Controlled Trials as Topic
Regression Analysis

Substances

Aspirin